https://peptidesagora.com/news/091226-biodexa-q2-2026-losses-peptide Peptides Agora en 2026-09-12T18:00:00.000Z https://peptidesagora.com/images/articles/biodexa-q2-2026-losses-peptide.jpg https://peptidesagora.com/news/091226-ganlee-doses-first-patient-oral-glp-1 Peptides Agora en 2026-09-12T18:00:00.000Z https://peptidesagora.com/images/articles/ganlee-doses-first-patient-oral-glp-1.jpg https://peptidesagora.com/news/091226-system-raises-20m-peptide-clinic-infrastructure Peptides Agora en 2026-09-12T18:00:00.000Z https://peptidesagora.com/images/articles/system-raises-20m-peptide-clinic-infrastructure.jpg https://peptidesagora.com/news/091226-twostep-62-5m-funding-peptide-ads-phase-1 Peptides Agora en 2026-09-12T18:00:00.000Z https://peptidesagora.com/images/articles/twostep-62-5m-funding-peptide-ads-phase-1.jpg https://peptidesagora.com/news/091226-wada-keeps-glp-1s-off-2027-banned-list Peptides Agora en 2026-09-12T18:00:00.000Z https://peptidesagora.com/images/articles/wada-keeps-glp-1s-off-2027-banned-list.jpg